Media

April 11, 2024

Consortium Hopes to Drive Adoption of Next-Gen Sequencing for Infectious Disease Diagnostics

April 10, 2024

2024 AAN Annual Meeting Top Science Press Conference

January 03, 2024

NextGen Class of 2024: Top Life Sciences Startups to Watch This Year

October 27, 2023

Delve Partners at UCSF Team Up with CDC to Confirm First US Case in Fungal Meningitis Outbreak

October 03, 2023

Delve founder, Dr. Joe DeRisi, interviewed on the latest episode of Science Friday podcast

September 13, 2023

Delve Bio Seeks to Commercialize UCSF Metagenomic Pathogen Test

September 13, 2023

Delve Bio Seeks to Commercialize UCSF Metagenomic Pathogen Test

September 09, 2023

Delve founder, Dr. Michael Wilson, MD has been selected as the recipient of the 2023 ANA Awards for Excellence

July 10, 2023

The Case of the Brain-Eating Amoeba

June 21, 2023

Delve Bio Launches with $35M Series A to Advance its Metagenomic Sequencing Platform for Infectious Disease Diagnosis

June 21, 2023

A New Company Looks for Culprits Behind Infections

June 20, 2023

Delve Bio Raises $35M in Series A Financing to Develop Metagenomic Sequencing Diagnostics
1 2 3
For inquiries, please visit our contact page.
Contact Us